Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD Axis II Criteria
NCT ID: NCT06774196
Last Updated: 2025-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2025-03-05
2025-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders
NCT00769561
Biobehavioral Pain Management in TMD
NCT01794624
Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)
NCT00066937
Behavioral Treatments for Chronic Pain
NCT00371865
Coherence Training for Military Personnel
NCT01599598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral Therapy Group
Participants receiving behavioral therapy (Cognitive Behavioral Therapy, relaxation techniques, and biofeedback).
Behavioral Therapy Group
Includes Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback.
Standard Care Group
Participants will receive standard care, consisting of pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy.
Standard Care Group
Includes pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Therapy Group
Includes Cognitive Behavioral Therapy (CBT), relaxation techniques, and biofeedback.
Standard Care Group
Includes pharmacological treatment (e.g., NSAIDs, muscle relaxants) and physical therapy interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with Temporomandibular Disorders (TMD) based on DC/TMD Axis I and Axis II criteria.
* Presenting with symptoms such as jaw pain, limited jaw movement, or psychosocial distress (anxiety, depression).
* Willing and able to provide informed consent.
* Able to comply with the study protocol and attend all follow-up visits.
Exclusion Criteria
* History of psychiatric disorders unrelated to TMD, such as schizophrenia or bipolar d disorder.
* Pregnant or lactating women.
* Use of medications or treatments within the past month that could influence study outcomes (e.g., corticosteroids, strong analgesics).
* Individuals with severe dental or maxillofacial conditions requiring immediate surgical intervention.
* Non-compliance with previous medical advice or treatment for TMD. Participants unable to understand or follow the study procedures due to language barriers or cognitive impairments.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Khalid University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sunil Kumar Vaddamanu
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Khalid University
Abhā, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECM#2024-3196
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.